Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis (International Journal of Impotence Research (2005) 17, (86-90) DOI: 10.1038/sj.ijir.3901284);Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis

International Journal of Impotence Research

Volumn 17, Issue 1, 2005, Pages 86-90

  Raina, R ^a,b   Agarwal, A ^a   Ausmundson, S ^a   Mansour, D ^b   Zippe, C D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alprostadil; Erectile dysfunction; MUSE; Radical prostatectomy; Sexual satisfaction

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DRUG EFFICACY; ERECTILE DYSFUNCTION; FOLLOW UP; HEALTH SURVEY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PENIS ERECTION; PRIORITY JOURNAL; PROSTATECTOMY; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL INTERCOURSE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; URETHRAL PAIN;

EID: 14544270997     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901621     Document Type: Erratum

References (12)

1. Zippe CD et al. Management of erectile dysfunction following radical prostatectomy. Curr Urol Rep 2001; 2: 495-503.
2. Zippe CD et al. Role of viagra after radical prostatectomy. Urology 2000; 55: 241-245.
3. Wilke RJ et al. Quality of life effects of alprostadil therapy for erectile dysfunction. J Urol 1997; 157: 2124-2129.
4. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996; 155: 802-815.
5. Padma-Nathan H et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997; 336: 1-7.
6. Fulgham PF et al. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol 1998; 160: 2041-2046.
7. Costabile RA et al. Safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1997; 157: 1424.
8. Montorsi F et al. Recovery of spontaneous erectile function after nerve sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective randomized trial. J Urol 1997; 161: 1914-1915.
9. Rosen RC et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822.
10. Rosen RC et al. Development and evaluation of an Abridged 5-Item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326.
11. Porst H. Transurethral alprostadil with MUSE versus intracavernous alprostadil: a comparative study in 103 patients with erectile dysfunction. Int J Impot Res 1997; 9: 187-192.
12. Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 2002; 14(Suppl 1): S38-S42.